Global Drugs for Malaria Market Research Report 2018 Opportunities, Size, Cost Structure, Service Provider, Segmentation, Shares, Forecast to 2024

Request for a SAMPLE REPORT

Fill up your details below and get the sample report for FREE

 Published Date : Jul-2018   |    Format :PDF   |    Number of Pages : 92
This report studies the global Drugs for Malaria market status and forecast, categorizes the global Drugs for Malaria market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease.
Anti-malarial Drugs are available only with a physician's prescription. They come in tablet, capsule, and injectable forms. Among the commonly used anti-malarial drugs are chloroquine, mefloquine, primaquine, pyrimethamine, and quinine.

The classification of drugs for malaria includes aryl aminoalcohol compounds, antifolate compounds and artemisinin compounds. The proportion of aryl aminoalcohol compounds drugs for malaria in 2016 is about 16.8%, the proportion of antifolate compounds in 2016 is about 55.4% and the proportion of artemisinin compounds in 2016 is about 27.8%.
Drugs for malaria are application in Preventioning malaria, curing malaria and other areas. The most of drugs for malaria is used in Preventioning malaria; the market share in 2016 is about 56.1%. And 35.1% of drugs for malaria are used in curing malaria.
Market competition is intense. The major manufacturers are Cipla, Guilin Pharmaceutical, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche, Novartis, Sanofi Aventis and Ajanta Pharma in the United States. 
The global Drugs for Malaria market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.

The major manufacturers covered in this report
    Cipla
    Guilin Pharmaceutical
    IPCA Laboratories
    GlaxoSmithKline
    Mylan Labs
    Roche
    Novartis
    Sanofi Aventis
    Ajanta Pharma

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India

We can also provide the customized separate regional or country-level reports, for the following regions:
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Rest of Asia-Pacific
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
        Rest of Europe
    Central & South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Saudi Arabia
        Turkey
        Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Aryl Aminoalcohol Compounds
    Antifolate Compounds
    Artemisinin Compounds
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Prevention
    Treatment
    Other

The study objectives of this report are:
    To analyze and study the global Drugs for Malaria sales, value, status (2013-2017) and forecast (2018-2025).
    Focuses on the key Drugs for Malaria manufacturers, to study the sales, value, market share and development plans in future.
    Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
    To define, describe and forecast the market by type, application and region.
    To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
    To identify significant trends and factors driving or inhibiting the market growth.
    To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
    To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Drugs for Malaria are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Drugs for Malaria Manufacturers
Drugs for Malaria Distributors/Traders/Wholesalers
Drugs for Malaria Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Drugs for Malaria market, by end-use.
Detailed analysis and profiles of additional market players.

Global Drugs for Malaria Market Research Report 2018
1 Drugs for Malaria Market Overview
    1.1 Product Overview and Scope of Drugs for Malaria
    1.2 Drugs for Malaria Segment by Type (Product Category)
        1.2.1 Global Drugs for Malaria Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
        1.2.2 Global Drugs for Malaria Production Market Share by Type (Product Category) in 2017
        1.2.3 Aryl Aminoalcohol Compounds
        1.2.4 Antifolate Compounds
        1.2.5 Artemisinin Compounds
    1.3 Global Drugs for Malaria Segment by Application
        1.3.1 Drugs for Malaria Consumption (Sales) Comparison by Application (2013-2025)
        1.3.2 Prevention
        1.3.3 Treatment
        1.3.4 Other
    1.4 Global Drugs for Malaria Market by Region (2013-2025)
        1.4.1 Global Drugs for Malaria Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
        1.4.2 North America Status and Prospect (2013-2025)
        1.4.3 Europe Status and Prospect (2013-2025)
        1.4.4 China Status and Prospect (2013-2025)
        1.4.5 Japan Status and Prospect (2013-2025)
        1.4.6 Southeast Asia Status and Prospect (2013-2025)
        1.4.7 India Status and Prospect (2013-2025)
    1.5 Global Market Size (Value) of Drugs for Malaria (2013-2025)
        1.5.1 Global Drugs for Malaria Revenue Status and Outlook (2013-2025)
        1.5.2 Global Drugs for Malaria Capacity, Production Status and Outlook (2013-2025)

2 Global Drugs for Malaria Market Competition by Manufacturers
    2.1 Global Drugs for Malaria Capacity, Production and Share by Manufacturers (2013-2018)
        2.1.1 Global Drugs for Malaria Capacity and Share by Manufacturers (2013-2018)
        2.1.2 Global Drugs for Malaria Production and Share by Manufacturers (2013-2018)
    2.2 Global Drugs for Malaria Revenue and Share by Manufacturers (2013-2018)
    2.3 Global Drugs for Malaria Average Price by Manufacturers (2013-2018)
    2.4 Manufacturers Drugs for Malaria Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Drugs for Malaria Market Competitive Situation and Trends
        2.5.1 Drugs for Malaria Market Concentration Rate
        2.5.2 Drugs for Malaria Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Drugs for Malaria Capacity, Production, Revenue (Value) by Region (2013-2018)
    3.1 Global Drugs for Malaria Capacity and Market Share by Region (2013-2018)
    3.2 Global Drugs for Malaria Production and Market Share by Region (2013-2018)
    3.3 Global Drugs for Malaria Revenue (Value) and Market Share by Region (2013-2018)
    3.4 Global Drugs for Malaria Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    3.5 North America Drugs for Malaria Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    3.6 Europe Drugs for Malaria Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    3.7 China Drugs for Malaria Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    3.8 Japan Drugs for Malaria Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    3.9 Southeast Asia Drugs for Malaria Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    3.10 India Drugs for Malaria Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

4 Global Drugs for Malaria Supply (Production), Consumption, Export, Import by Region (2013-2018)
    4.1 Global Drugs for Malaria Consumption by Region (2013-2018)
    4.2 North America Drugs for Malaria Production, Consumption, Export, Import (2013-2018)
    4.3 Europe Drugs for Malaria Production, Consumption, Export, Import (2013-2018)
    4.4 China Drugs for Malaria Production, Consumption, Export, Import (2013-2018)
    4.5 Japan Drugs for Malaria Production, Consumption, Export, Import (2013-2018)
    4.6 Southeast Asia Drugs for Malaria Production, Consumption, Export, Import (2013-2018)
    4.7 India Drugs for Malaria Production, Consumption, Export, Import (2013-2018)

5 Global Drugs for Malaria Production, Revenue (Value), Price Trend by Type
    5.1 Global Drugs for Malaria Production and Market Share by Type (2013-2018)
    5.2 Global Drugs for Malaria Revenue and Market Share by Type (2013-2018)
    5.3 Global Drugs for Malaria Price by Type (2013-2018)
    5.4 Global Drugs for Malaria Production Growth by Type (2013-2018)

6 Global Drugs for Malaria Market Analysis by Application
    6.1 Global Drugs for Malaria Consumption and Market Share by Application (2013-2018)
    6.2 Global Drugs for Malaria Consumption Growth Rate by Application (2013-2018)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Drugs for Malaria Manufacturers Profiles/Analysis
    7.1 Cipla
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Drugs for Malaria Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 Cipla Drugs for Malaria Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        7.1.4 Main Business/Business Overview
    7.2 Guilin Pharmaceutical
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Drugs for Malaria Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 Guilin Pharmaceutical Drugs for Malaria Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        7.2.4 Main Business/Business Overview
    7.3 IPCA Laboratories
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Drugs for Malaria Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 IPCA Laboratories Drugs for Malaria Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        7.3.4 Main Business/Business Overview
    7.4 GlaxoSmithKline
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Drugs for Malaria Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 GlaxoSmithKline Drugs for Malaria Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        7.4.4 Main Business/Business Overview
    7.5 Mylan Labs
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Drugs for Malaria Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Mylan Labs Drugs for Malaria Capacity, Production, Revenue, Price and Gross Margin (2015-2018)
        7.5.4 Main Business/Business Overview
    7.6 Roche
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Drugs for Malaria Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Roche Drugs for Malaria Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        7.6.4 Main Business/Business Overview
    7.7 Novartis
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Drugs for Malaria Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 Novartis Drugs for Malaria Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        7.7.4 Main Business/Business Overview
    7.8 Sanofi Aventis
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Drugs for Malaria Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 Sanofi Aventis Drugs for Malaria Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        7.8.4 Main Business/Business Overview
    7.9 Ajanta Pharma
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Drugs for Malaria Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 Ajanta Pharma Drugs for Malaria Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        7.9.4 Main Business/Business Overview

8 Drugs for Malaria Manufacturing Cost Analysis
    8.1 Drugs for Malaria Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Drugs for Malaria

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Drugs for Malaria Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Drugs for Malaria Major Manufacturers in 2017
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Drugs for Malaria Market Forecast (2018-2025)
    12.1 Global Drugs for Malaria Capacity, Production, Revenue Forecast (2018-2025)
        12.1.1 Global Drugs for Malaria Capacity, Production and Growth Rate Forecast (2018-2025)
        12.1.2 Global Drugs for Malaria Revenue and Growth Rate Forecast (2018-2025)
        12.1.3 Global Drugs for Malaria Price and Trend Forecast (2018-2025)
    12.2 Global Drugs for Malaria Production, Consumption , Import and Export Forecast by Region (2018-2025)
        12.2.1 North America Drugs for Malaria Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        12.2.2 Europe Drugs for Malaria Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        12.2.3 China Drugs for Malaria Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        12.2.4 Japan Drugs for Malaria Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        12.2.5 Southeast Asia Drugs for Malaria Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        12.2.6 India Drugs for Malaria Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
    12.3 Global Drugs for Malaria Production, Revenue and Price Forecast by Type (2018-2025)
    12.4 Global Drugs for Malaria Consumption Forecast by Application (2018-2025)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer



List of Tables and Figures

    Figure Picture of Drugs for Malaria
    Figure Global Drugs for Malaria Production () and CAGR (%) Comparison by Types (Product Category) (2013-2025)
    Figure Global Drugs for Malaria Production Market Share by Types (Product Category) in 2017
    Figure Product Picture of Aryl Aminoalcohol Compounds
    Table Major Manufacturers of Aryl Aminoalcohol Compounds
    Figure Product Picture of Antifolate Compounds
    Table Major Manufacturers of Antifolate Compounds
    Figure Product Picture of Artemisinin Compounds
    Table Major Manufacturers of Artemisinin Compounds
    Figure Global Drugs for Malaria Consumption (K Units) by Applications (2013-2025)
    Figure Global Drugs for Malaria Consumption Market Share by Applications in 2017
    Figure Prevention Examples
    Table Key Downstream Customer in Prevention
    Figure Treatment Examples
    Table Key Downstream Customer in Treatment
    Figure Other Examples
    Table Key Downstream Customer in Other
    Figure Global Drugs for Malaria Market Size (Million USD), Comparison (K Units) and CAGR (%) by Regions (2013-2025)
    Figure North America Drugs for Malaria Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Europe Drugs for Malaria Revenue (Million USD) and Growth Rate (2013-2025)
    Figure China Drugs for Malaria Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Japan Drugs for Malaria Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Southeast Asia Drugs for Malaria Revenue (Million USD) and Growth Rate (2013-2025)
    Figure India Drugs for Malaria Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Global Drugs for Malaria Revenue (Million USD) Status and Outlook (2013-2025)
    Figure Global Drugs for Malaria Capacity, Production (K Units) Status and Outlook (2013-2025)
    Figure Global Drugs for Malaria Major Players Product Capacity (K Units) (2013-2018)
    Table Global Drugs for Malaria Capacity (K Units) of Key Manufacturers (2013-2018)
    Table Global Drugs for Malaria Capacity Market Share of Key Manufacturers (2013-2018)
    Figure Global Drugs for Malaria Capacity (K Units) of Key Manufacturers in 2017
    Figure Global Drugs for Malaria Capacity (K Units) of Key Manufacturers in 2018
    Figure Global Drugs for Malaria Major Players Product Production (K Units) (2013-2018)
    Table Global Drugs for Malaria Production (K Units) of Key Manufacturers (2013-2018)
    Table Global Drugs for Malaria Production Share by Manufacturers (2013-2018)
    Figure 2017 Drugs for Malaria Production Share by Manufacturers
    Figure 2017 Drugs for Malaria Production Share by Manufacturers
    Figure Global Drugs for Malaria Major Players Product Revenue (Million USD) (2013-2018)
    Table Global Drugs for Malaria Revenue (Million USD) by Manufacturers (2013-2018)
    Table Global Drugs for Malaria Revenue Share by Manufacturers (2013-2018)
    Table 2017 Global Drugs for Malaria Revenue Share by Manufacturers
    Table 2018 Global Drugs for Malaria Revenue Share by Manufacturers
    Table Global Market Drugs for Malaria Average Price (USD/Unit) of Key Manufacturers (2013-2018)
    Figure Global Market Drugs for Malaria Average Price (USD/Unit) of Key Manufacturers in 2017
    Table Manufacturers Drugs for Malaria Manufacturing Base Distribution and Sales Area
    Table Manufacturers Drugs for Malaria Product Category
    Figure Drugs for Malaria Market Share of Top 3 Manufacturers
    Figure Drugs for Malaria Market Share of Top 5 Manufacturers
    Table Global Drugs for Malaria Capacity (K Units) by Region (2013-2018)
    Figure Global Drugs for Malaria Capacity Market Share by Region (2013-2018)
    Figure Global Drugs for Malaria Capacity Market Share by Region (2013-2018)
    Figure 2017 Global Drugs for Malaria Capacity Market Share by Region
    Table Global Drugs for Malaria Production by Region (2013-2018)
    Figure Global Drugs for Malaria Production (K Units) by Region (2013-2018)
    Figure Global Drugs for Malaria Production Market Share by Region (2013-2018)
    Figure 2017 Global Drugs for Malaria Production Market Share by Region
    Table Global Drugs for Malaria Revenue (Million USD) by Region (2013-2018)
    Table Global Drugs for Malaria Revenue Market Share by Region (2013-2018)
    Figure Global Drugs for Malaria Revenue Market Share by Region (2013-2018)
    Table 2017 Global Drugs for Malaria Revenue Market Share by Region
    Figure Global Drugs for Malaria Capacity, Production (K Units) and Growth Rate (2013-2018)
    Table Global Drugs for Malaria Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Table North America Drugs for Malaria Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Table Europe Drugs for Malaria Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Table China Drugs for Malaria Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Table Japan Drugs for Malaria Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Table China Drugs for Malaria Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Table Japan Drugs for Malaria Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Table Global Drugs for Malaria Consumption (K Units) Market by Region (2013-2018)
    Table Global Drugs for Malaria Consumption Market Share by Region (2013-2018)
    Figure Global Drugs for Malaria Consumption Market Share by Region (2013-2018)
    Figure 2017 Global Drugs for Malaria Consumption (K Units) Market Share by Region
    Table North America Drugs for Malaria Production, Consumption, Import & Export (K Units) (2013-2018)
    Table Europe Drugs for Malaria Production, Consumption, Import & Export (K Units) (2013-2018)
    Table China Drugs for Malaria Production, Consumption, Import & Export (K Units) (2013-2018)
    Table Japan Drugs for Malaria Production, Consumption, Import & Export (K Units) (2013-2018)
    Table Southeast Asia Drugs for Malaria Production, Consumption, Import & Export (K Units) (2013-2018)
    Table India Drugs for Malaria Production, Consumption, Import & Export (K Units) (2013-2018)
    Table Global Drugs for Malaria Production (K Units) by Type (2013-2018)
    Table Global Drugs for Malaria Production Share by Type (2013-2018)
    Figure Production Market Share of Drugs for Malaria by Type (2013-2018)
    Figure 2017 Production Market Share of Drugs for Malaria by Type
    Table Global Drugs for Malaria Revenue (Million USD) by Type (2013-2018)
    Table Global Drugs for Malaria Revenue Share by Type (2013-2018)
    Figure Production Revenue Share of Drugs for Malaria by Type (2013-2018)
    Figure 2017 Revenue Market Share of Drugs for Malaria by Type
    Table Global Drugs for Malaria Price (USD/Unit) by Type (2013-2018)
    Figure Global Drugs for Malaria Production Growth by Type (2013-2018)
    Table Global Drugs for Malaria Consumption (K Units) by Application (2013-2018)
    Table Global Drugs for Malaria Consumption Market Share by Application (2013-2018)
    Figure Global Drugs for Malaria Consumption Market Share by Applications (2013-2018)
    Figure Global Drugs for Malaria Consumption Market Share by Application in 2017
    Table Global Drugs for Malaria Consumption Growth Rate by Application (2013-2018)
    Figure Global Drugs for Malaria Consumption Growth Rate by Application (2013-2018)
    Table Cipla Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Cipla Drugs for Malaria Capacity, Production (K Units), Revenue (Million USD), Price (Cipla) and Gross Margin (2013-2018)
    Figure Cipla Drugs for Malaria Production Growth Rate (2013-2018)
    Figure Cipla Drugs for Malaria Production Market Share (2013-2018)
    Figure Cipla Drugs for Malaria Revenue Market Share (2013-2018)
    Table Guilin Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Guilin Pharmaceutical Drugs for Malaria Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Guilin Pharmaceutical Drugs for Malaria Production Growth Rate (2013-2018)
    Figure Guilin Pharmaceutical Drugs for Malaria Production Market Share (2013-2018)
    Figure Guilin Pharmaceutical Drugs for Malaria Revenue Market Share (2013-2018)
    Table IPCA Laboratories Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table IPCA Laboratories Drugs for Malaria Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure IPCA Laboratories Drugs for Malaria Production Growth Rate (2013-2018)
    Figure IPCA Laboratories Drugs for Malaria Production Market Share (2013-2018)
    Figure IPCA Laboratories Drugs for Malaria Revenue Market Share (2013-2018)
    Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table GlaxoSmithKline Drugs for Malaria Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure GlaxoSmithKline Drugs for Malaria Production Growth Rate (2013-2018)
    Figure GlaxoSmithKline Drugs for Malaria Production Market Share (2013-2018)
    Figure GlaxoSmithKline Drugs for Malaria Revenue Market Share (2013-2018)
    Table Mylan Labs Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Mylan Labs Drugs for Malaria Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Mylan Labs Drugs for Malaria Production Growth Rate (2013-2018)
    Figure Mylan Labs Drugs for Malaria Production Market Share (2013-2018)
    Figure Mylan Labs Drugs for Malaria Revenue Market Share (2013-2018)
    Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Roche Drugs for Malaria Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Roche Drugs for Malaria Production Growth Rate (2013-2018)
    Figure Roche Drugs for Malaria Production Market Share (2013-2018)
    Figure Roche Drugs for Malaria Revenue Market Share (2013-2018)
    Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Novartis Drugs for Malaria Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Novartis Drugs for Malaria Production Growth Rate (2013-2018)
    Figure Novartis Drugs for Malaria Production Market Share (2013-2018)
    Figure Novartis Drugs for Malaria Revenue Market Share (2013-2018)
    Table Sanofi Aventis Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Sanofi Aventis Drugs for Malaria Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Sanofi Aventis Drugs for Malaria Production Growth Rate (2013-2018)
    Figure Sanofi Aventis Drugs for Malaria Production Market Share (2013-2018)
    Figure Sanofi Aventis Drugs for Malaria Revenue Market Share (2013-2018)
    Table Ajanta Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Ajanta Pharma Drugs for Malaria Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Ajanta Pharma Drugs for Malaria Production Growth Rate (2013-2018)
    Figure Ajanta Pharma Drugs for Malaria Production Market Share (2013-2018)
    Figure Ajanta Pharma Drugs for Malaria Revenue Market Share (2013-2018)
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Drugs for Malaria
    Figure Manufacturing Process Analysis of Drugs for Malaria
    Figure Drugs for Malaria Industrial Chain Analysis
    Table Raw Materials Sources of Drugs for Malaria Major Manufacturers in 2017
    Table Major Buyers of Drugs for Malaria
    Table Distributors/Traders List
    Figure Global Drugs for Malaria Capacity, Production (K Units) and Growth Rate Forecast (2018-2025)
    Figure Global Drugs for Malaria Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Figure Global Drugs for Malaria Price (Million USD) and Trend Forecast (2018-2025)
    Table Global Drugs for Malaria Production (K Units) Forecast by Region (2018-2025)
    Figure Global Drugs for Malaria Production Market Share Forecast by Region (2018-2025)
    Table Global Drugs for Malaria Consumption (K Units) Forecast by Region (2018-2025)
    Figure Global Drugs for Malaria Consumption Market Share Forecast by Region (2018-2025)
    Figure North America Drugs for Malaria Production (K Units) and Growth Rate Forecast (2018-2025)
    Figure North America Drugs for Malaria Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Table North America Drugs for Malaria Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
    Figure Europe Drugs for Malaria Production (K Units) and Growth Rate Forecast (2018-2025)
    Figure Europe Drugs for Malaria Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Table Europe Drugs for Malaria Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
    Figure China Drugs for Malaria Production (K Units) and Growth Rate Forecast (2018-2025)
    Figure China Drugs for Malaria Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Table China Drugs for Malaria Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
    Figure Japan Drugs for Malaria Production (K Units) and Growth Rate Forecast (2018-2025)
    Figure Japan Drugs for Malaria Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Table Japan Drugs for Malaria Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
    Figure Southeast Asia Drugs for Malaria Production (K Units) and Growth Rate Forecast (2018-2025)
    Figure Southeast Asia Drugs for Malaria Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Table Southeast Asia Drugs for Malaria Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
    Figure India Drugs for Malaria Production (K Units) and Growth Rate Forecast (2018-2025)
    Figure India Drugs for Malaria Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Table India Drugs for Malaria Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
    Table Global Drugs for Malaria Production (K Units) Forecast by Type (2018-2025)
    Figure Global Drugs for Malaria Production (K Units) Forecast by Type (2018-2025)
    Table Global Drugs for Malaria Revenue (Million USD) Forecast by Type (2018-2025)
    Figure Global Drugs for Malaria Revenue Market Share Forecast by Type (2018-2025)
    Table Global Drugs for Malaria Price Forecast by Type (2018-2025)
    Table Global Drugs for Malaria Consumption (K Units) Forecast by Application (2018-2025)
    Figure Global Drugs for Malaria Consumption (K Units) Forecast by Application (2018-2025)
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Source

Latest News

25-Feb-2019 | Medical Devices

Launch Of Symjepi Epinephrine Syringe To Boost The Syringe Market Growth In US

A rising burden of chronic diseases has been observed all across the world, which, in turn, has elevated the usage of syringes. Overall, the global syringe market is anticipated to observe vigorous ...

25-Feb-2019 | Electrical & Electronic Device

Launch Of Xiaomi Set-Top Box To Power The Global 4K Set-Top Box Market

While smart TVs are turning out to be much more widespread these days, a number of consumers still choose to opt for normal TVs and then employ smart streaming set top box with them. Popular choice ...

13-Feb-2019 | Software

Bioinspired Artificial Bug Eye Creation Is A Baton For Global Autonomous Car Market

After looking at the different eye lens structures of the animals and humans, the researchers have decided on creating a sharp image using its design. The compound eyes of the bugs are currently be ...

13-Feb-2019 | Consumer Goods & Retailing

Cafe X’s $12 Million “Seed-1” Round To Boost The Global Coffee Market

Cafe X, a company engaged in building robot baristas, is about to raise a $12 Million “Seed-1” round. Recently, Crunchbase News broke the story when it came across regulatory f ...

05-Feb-2019 | Chemicals & Materials

Clinically Produced Cells Change The Horizon Of Global Bone Cement And Glue Market

The group of researchers from the New York Stem Cell Foundation Research Institute published an article in Stem Cell Research and Therapy where the details regarding the clinical ...